191 related articles for article (PubMed ID: 17296194)
1. The value of Chlamydia trachomatis-specific IgG antibody testing and hysterosalpingography for predicting tubal pathology and occurrence of pregnancy.
Perquin DA; Beersma MF; de Craen AJ; Helmerhorst FM
Fertil Steril; 2007 Jul; 88(1):224-6. PubMed ID: 17296194
[TBL] [Abstract][Full Text] [Related]
2. Chlamydial serology and histerosalpingography in predicting tubal disease in infertility patients.
Fiçicioğlu C; Api M
Acta Eur Fertil; 1995; 26(3):109-12. PubMed ID: 9098470
[TBL] [Abstract][Full Text] [Related]
3. The role of chlamydia genus-specific and species-specific IgG antibody testing in predicting tubal disease in subfertile women.
den Hartog JE; Land JA; Stassen FR; Slobbe-van Drunen ME; Kessels AG; Bruggeman CA
Hum Reprod; 2004 Jun; 19(6):1380-4. PubMed ID: 15105400
[TBL] [Abstract][Full Text] [Related]
4. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility.
den Hartog JE; Land JA; Stassen FR; Kessels AG; Bruggeman CA
Hum Reprod; 2005 Apr; 20(4):986-90. PubMed ID: 15640255
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology.
Coppus SF; Land JA; Opmeer BC; Steures P; Eijkemans MJ; Hompes PG; Bossuyt PM; van der Veen F; Mol BW; van der Steeg JW
Hum Reprod; 2011 Nov; 26(11):3061-7. PubMed ID: 21926058
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia serology screening in infertility patients.
Keltz MD; Gera PS; Moustakis M
Fertil Steril; 2006 Mar; 85(3):752-4. PubMed ID: 16500355
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis antibody titers and hysterosalpingography in predicting tubal disease in infertility patients.
Meikle SF; Zhang X; Marine WM; Calonge BN; Hamman RF; Betz G
Fertil Steril; 1994 Aug; 62(2):305-12. PubMed ID: 8034077
[TBL] [Abstract][Full Text] [Related]
8. [Anti-C. trachomatis IgG antibodies levels in serum to identify infertility caused by tubal damage].
Hernández-Trejo M; López-Hurtado M; Arteaga-Troncoso G; Guerra-Infante FM
Rev Invest Clin; 2009; 61(1):87-9. PubMed ID: 19507478
[TBL] [Abstract][Full Text] [Related]
9. [Chlamydia antibody testing for tubal factor subfertility].
Lardenoije CM; Land JA
Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1981-5. PubMed ID: 17953171
[TBL] [Abstract][Full Text] [Related]
10. Positive Chlamydia trachomatis serology result in women seeking care for infertility is a negative prognosticator for intrauterine pregnancy.
Keltz MD; Sauerbrun-Cutler MT; Durante MS; Moshier E; Stein DE; Gonzales E
Sex Transm Dis; 2013 Nov; 40(11):842-5. PubMed ID: 24113404
[TBL] [Abstract][Full Text] [Related]
11. Screening strategies for tubal factor subfertility.
den Hartog JE; Lardenoije CM; Severens JL; Land JA; Evers JL; Kessels AG
Hum Reprod; 2008 Aug; 23(8):1840-8. PubMed ID: 18579509
[TBL] [Abstract][Full Text] [Related]
12. [The most suitable tests for studying chlamydial infection in women with sterility].
Borisov I; Nalbanski B; Filipov E; Pŭnevska M; Kolarov G
Akush Ginekol (Sofiia); 1999; 38(4):23-5. PubMed ID: 10726347
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis infection in fertile and subfertile women in Rwanda: prevalence and diagnostic significance of IgG and IgA antibodies testing.
Muvunyi CM; Dhont N; Verhelst R; Temmerman M; Claeys G; Padalko E
Hum Reprod; 2011 Dec; 26(12):3319-26. PubMed ID: 22016415
[TBL] [Abstract][Full Text] [Related]
14. Utilizing Chlamydia trachomatis IgG serology with HSG to diagnose tuboperitoneal-factor infertility.
Bernstein RC; Yalcinkaya TM
W V Med J; 2003; 99(3):105-7. PubMed ID: 14515433
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of medical history taking and Chlamydia IgG ELISA antibody testing (CAT) in the selection of subfertile women for diagnostic laparoscopy: a clinical prediction model approach.
Coppus SF; Opmeer BC; Logan S; van der Veen F; Bhattacharya S; Mol BW
Hum Reprod; 2007 May; 22(5):1353-8. PubMed ID: 17234674
[TBL] [Abstract][Full Text] [Related]
16. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology.
Mouton JW; Peeters MF; van Rijssort-Vos JH; Verkooyen RP
Int J STD AIDS; 2002 Dec; 13 Suppl 2():26-9. PubMed ID: 12537722
[TBL] [Abstract][Full Text] [Related]
17. Integration of patient characteristics and the results of Chlamydia antibody testing and hysterosalpingography in the diagnosis of tubal pathology: an individual patient data meta-analysis.
Broeze KA; Opmeer BC; Coppus SF; Van Geloven N; Den Hartog JE; Land JA; Van der Linden PJ; Ng EH; Van der Steeg JW; Steures P; Van der Veen F; Mol BW
Hum Reprod; 2012 Oct; 27(10):2979-90. PubMed ID: 22851718
[TBL] [Abstract][Full Text] [Related]
18. [The effect of chlamydial infection on tubal patency].
Nalbanski B; Borisov I; Slavkova V; Filipov E
Akush Ginekol (Sofiia); 1999; 38(3):22-4. PubMed ID: 10734674
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia antibody testing in subfertile women.
Land JA; den Hartog JE
Drugs Today (Barc); 2006 Mar; 42 Suppl A():35-42. PubMed ID: 16683042
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis antibody testing is more accurate than hysterosalpingography in predicting tubal factor infertility.
Dabekausen YA; Evers JL; Land JA; Stals FS
Fertil Steril; 1994 May; 61(5):833-7. PubMed ID: 8174718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
